The 3 Conditions Driving Healthcare Costs Up For Employers: Report

Pharmacy, cancer and musculoskeletal conditions remain the top drivers of increased healthcare costs for employers, but cardiovascular conditions are on the rise as well, a Business Group on Health report found.

Business Group of Health’s “2025 Employer Health Care Strategy Survey” surveyed 125 large employers across varied industries who together cover 17.1 million workers. The survey was conducted between June 3 and July 12.

The survey found projected healthcare costs will jump almost 8% in 2025, the highest in more than a decade. The increase comes among heightened demand for expensive drugs such as GLP-1s and the ongoing burden of treating cancer and other chronic conditions.

“Employers are steadfast in their desire to provide comprehensive offerings to their workforces,” Ellen Kelsay, president and CEO of Business Group on Health, a nonprofit, said in an Aug. 20 company news release. “They continue to absorb much of the upticks in cost and remain keenly focused on lowering spending and improving outcomes and experiences for employees. However, the foreboding cost landscape has accelerated the need for bold transformation, and employers seek partners who will make that happen.”

Here are eight findings to know:

  1. Healthcare costs are expected to grow almost 8% for 2025, compared to 6% in 2022, and employers report being prepared to absorb the increases while leaning into additional costs management strategies.

2. Pharmacy costs are largely responsible for the increases, and 76% of employers said they were “very concerned” about the overall pharmacy costs. Healthcare spend attributed to pharmacy rose from 21% in 2021 to 27% in 2023.

3. GLP-1 medications were the top driver of pharmacy costs.

4. About 79% of employers said they saw heightened interest in obesity medication and 96% are concerned about the long-term cost implications.

5. Cancer remained the top condition driving costs up, but cardiovascular conditions were also in the top three cost drivers for 40% of employers, compared to 30% in 2023.

6. Cancer treatment needs are increasingly prevalent among the younger workforce, but employers said they wanted to boost cancer prevention efforts.

7. More employers are eying nontraditional health plans and transparent pharmacy benefit managers to lower costs and simplify member experience.

8. Improving access to mental health is a priority in 2025 for 79% of employers, who are pursuing strategies for no- or low-cost virtual counseling and eliminating out-of-network barriers.

Source Link

Recommended Articles

Trump Administration Demands Hospitals Share Emergency Room Records

A tiny federal agency tasked with protecting the public from injuries caused by lawn mowers and coffeemakers is demanding that some of the nation’s biggest health systems turn over detailed, personally identifiable medical records of all patients who seek help at their emergency rooms. The Consumer Product Safety Commission, responsible for tracking and issuing recalls ...

Read More

21 States File Lawsuit Challenging 2027 ACA Payment Rule

A coalition of attorneys general from 21 states, along with Pennsylvania Gov. Josh Shapiro, have filed a lawsuit challenging a federal rule that they allege undermines the Affordable Care Act and makes health insurance more expensive and harder to obtain for millions of Americans. The lawsuit seeks to block provisions of the Trump administration’s ACA ...

Read More

Erica Schwartz, Trump’s CDC Pick Wins Senate Confirmation

The Senate voted to confirm President Donald Trump’s nominee, Erica Schwartz, to run the Centers for Disease Control and Prevention on Wednesday, ending a nearly yearlong period without a Senate-confirmed director leading the agency. Schwartz was confirmed in a 51-44 vote, with Sen. Tim Kaine (D-Va.) joining Republicans in support. All other Democrats opposed the nomination. Despite a ...

Read More

Specialty Drug Costs Expected To Jump 32% By 2028, PSG Finds

Specialty drug trend remains high, although it decreased from 11.2% to 10.8% on a gross cost basis in Pharmacy Strategies Group’s 2026 State of Specialty Spend and Trend Report. Claim utilization is now the dominant driver of specialty drug trend as the percentage of members using specialty drugs rose to 5.5%. “For a decade, this report ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square